Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Brookhaven Instruments Corporation is a leading designer and manufacturer of analytical instruments for particle characterization, specializing in nanoparticle size, zeta potential, and molecular weight measurements. Founded in 1981 and headquartered in Holtsville, New York, the company provides critical tools for research and development in the biotechnology, pharmaceutical, and materials science industries. Its products, such as the NanoBrook series and the BI-200SM goniometer, are essential for characterizing drug delivery systems, proteins, and polymers. Brookhaven Instruments was acquired by Nova Instruments Corporation in 2015 and continues to operate as a key subsidiary in the life sciences technology sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Brookhaven.